Login to get the latest articles, videos,
gallery, and a lot more…
or continue with
Email
Google
Facebook
To get RegisteredSignup now
The Next Ozempic? New 4-in-1 Weight Loss Drug Could Treat Obesity, Diabetes, Cancer And Heart Diseases
Credits: Health and me
SummaryScientists have developed a new 4-in-1 weight loss drug combining GLP-1, GIP, glucagon, and PYY hormones, aiming to match bariatric surgery-level results while reducing obesity-related risks like diabetes, cancer, and heart disease. As the demands for weight loss drugs skyrockets, a more powerful, safer option could reshape the market and, more importantly, redefine the role of pharmacology in preventing chronic disease.
End of Article